NFE2L2 and Parkinson disease: Studies with Nrf2 KO mice models have reported a greater loss of dopamine transporter levels within the striatum following 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (MPTP) treatment, a pharmacologically induced model of PD, inducing neurotoxicity [171].